AT365611B - Verfahren zur herstellung von neuen 17alpha-(3-r2-oxypropyl)-17beta-r1-oxy-4-gonen-onen - Google Patents

Verfahren zur herstellung von neuen 17alpha-(3-r2-oxypropyl)-17beta-r1-oxy-4-gonen-onen

Info

Publication number
AT365611B
AT365611B AT0141377A AT141377A AT365611B AT 365611 B AT365611 B AT 365611B AT 0141377 A AT0141377 A AT 0141377A AT 141377 A AT141377 A AT 141377A AT 365611 B AT365611 B AT 365611B
Authority
AT
Austria
Prior art keywords
gonen
17alpha
17beta
oxypropyl
oxy
Prior art date
Application number
AT0141377A
Other languages
English (en)
Other versions
ATA141377A (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762609695 external-priority patent/DE2609695A1/de
Priority claimed from DE19762609694 external-priority patent/DE2609694C3/de
Priority claimed from DE19762627186 external-priority patent/DE2627186A1/de
Priority claimed from DE19762627187 external-priority patent/DE2627187A1/de
Priority claimed from DE19762644427 external-priority patent/DE2644427A1/de
Priority claimed from DE19762646043 external-priority patent/DE2646043C2/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of ATA141377A publication Critical patent/ATA141377A/de
Application granted granted Critical
Publication of AT365611B publication Critical patent/AT365611B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0141377A 1976-03-05 1977-03-03 Verfahren zur herstellung von neuen 17alpha-(3-r2-oxypropyl)-17beta-r1-oxy-4-gonen-onen AT365611B (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE19762609695 DE2609695A1 (de) 1976-03-05 1976-03-05 7-substituierte 4-androsten-3-one und verfahren zu ihrer herstellung
DE19762609694 DE2609694C3 (de) 1976-03-05 1976-03-05 17 a-(3-Hydroxpropyl)-17 ß- hydroxy-7 a-thioalkanoyl-4-androsten- 3-one und Verfahren zu deren Herstellung
DE19762627186 DE2627186A1 (de) 1976-03-05 1976-06-16 7-substituierte 4-androsten-3-one und verfahren zu ihrer herstellung iii
DE19762627187 DE2627187A1 (de) 1976-06-16 1976-06-16 7-substituierte 4-androsten-3-one und verfahren zu ihrer herstellung ii
DE19762644427 DE2644427A1 (de) 1976-09-30 1976-09-30 17 beta-hydroxy-17 alpha-(3-acyloxypropyl)-4.6-androstadien-3-one und deren salze
DE19762646043 DE2646043C2 (de) 1976-10-08 1976-10-08 7α-Acetylthio-6α-methyl-4-androsten-3-one, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
ATA141377A ATA141377A (de) 1981-06-15
AT365611B true AT365611B (de) 1982-02-10

Family

ID=27544260

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0141377A AT365611B (de) 1976-03-05 1977-03-03 Verfahren zur herstellung von neuen 17alpha-(3-r2-oxypropyl)-17beta-r1-oxy-4-gonen-onen
AT0180980A AT370110B (de) 1976-03-05 1980-04-02 Verfahren zur herstellung von neuen 4-androsten-3-onen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT0180980A AT370110B (de) 1976-03-05 1980-04-02 Verfahren zur herstellung von neuen 4-androsten-3-onen

Country Status (15)

Country Link
US (1) US4118488A (de)
JP (1) JPS52111552A (de)
AT (2) AT365611B (de)
BE (1) BE852089A (de)
CA (1) CA1078826A (de)
CH (1) CH631462A5 (de)
DD (1) DD128659A5 (de)
DK (1) DK146856C (de)
FR (1) FR2342990A1 (de)
GB (1) GB1579298A (de)
IE (1) IE44711B1 (de)
IL (1) IL51586A (de)
LU (1) LU76883A1 (de)
NL (1) NL7702369A (de)
SE (1) SE420732B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53116361A (en) * 1977-03-17 1978-10-11 Mitsubishi Chem Ind Ltd Preparation of 7 acylthioo44enee33oxosteroid
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.
DE3111951A1 (de) * 1981-03-23 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 7(alpha)-alkoxycarbonyl-15ss-methylen-4-androstene, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3130644A1 (de) * 1981-07-29 1983-02-17 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
DE3461090D1 (en) * 1983-02-18 1986-12-04 Schering Ag 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
US4552871A (en) * 1983-04-13 1985-11-12 Ciba Geigy Corporation Steroids of the 20-spiroxane series, processes for the manufacture thereof, pharmaceutical preparations containing such compounds and the use of the latter
ATE365171T1 (de) * 1995-12-11 2007-07-15 Searle Llc Verfahren zur herstellung einer epoxyverbindung
US6887991B1 (en) * 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
ATE375992T1 (de) 1996-12-11 2007-11-15 Searle Llc Epoxidierungsverfahren
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
SI1487859T1 (sl) * 2002-03-22 2008-10-31 Pharmacia & Upjohn Co Llc Postopek priprave eplerenona
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137690A (en) * 1963-09-26 1964-06-16 Searle & Co 17beta-hydroxy-3-oxoandrost-4-en-17alpha-ylpropionaldehyde lactol and delta1, delta6, delta1, 6, 19-nor and 7alpha-acetylthio congeners
DE1250818B (de) * 1963-10-01 1967-09-28 G. D. Searle & Co., Chicago, 111. (V. St. A.) Verfahren zur Herstellung von 3-Oxozl4.Asteroiden
US3798213A (en) * 1971-01-25 1974-03-19 Merck & Co Inc 7 alpha-methyl-20-spiroxane-3-ones and process
US3753979A (en) * 1971-12-06 1973-08-21 Merck & Co Inc Substituted 1,2alpha-methylene-6,7alpha-halomethylene-20-spirox-4-en-3-ones or 3-ols and acyl esters thereof
DE2251476A1 (de) * 1972-10-20 1974-05-02 Hoechst Ag Verfahren zur herstellung von beta(3-keto-7 alpha-thioacyl-17 beta-hydroxy4-androsten-17 alpha -yl)-propionsaeuregamma -lactonen
CH609357A5 (de) * 1973-05-25 1979-02-28 Schering Ag

Also Published As

Publication number Publication date
ATA141377A (de) 1981-06-15
FR2342990B1 (de) 1979-03-09
CH631462A5 (de) 1982-08-13
IE44711B1 (en) 1982-03-10
DK96177A (da) 1977-09-06
NL7702369A (nl) 1977-09-07
SE420732B (sv) 1981-10-26
AT370110B (de) 1983-03-10
IE44711L (en) 1977-09-05
JPS52111552A (en) 1977-09-19
SE7702455L (sv) 1977-09-06
ATA180980A (de) 1982-07-15
BE852089A (fr) 1977-09-05
IL51586A (en) 1981-10-30
IL51586A0 (en) 1977-05-31
GB1579298A (en) 1980-11-19
DD128659A5 (de) 1977-11-30
LU76883A1 (de) 1977-07-11
DK146856C (da) 1984-07-02
US4118488A (en) 1978-10-03
FR2342990A1 (fr) 1977-09-30
DK146856B (da) 1984-01-23
CA1078826A (en) 1980-06-03

Similar Documents

Publication Publication Date Title
AT356827B (de) Verfahren zur herstellung von neuen spirol- actonen
AT355571B (de) Verfahren zur herstellung von neuen bis -pyridinium-verbindungen
AT358727B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT356136B (de) Verfahren zur herstellung von neuen spiro- hydantoinen
AT363478B (de) Verfahren zur herstellung von neuen oxepanderivaten
AT359187B (de) Verfahren zur herstellung von neuen 7-beta-(2- -oxyimino-2-arylacetamido)-cephalosporinen
AT370110B (de) Verfahren zur herstellung von neuen 4-androsten-3-onen
AT360185B (de) Verfahren zur herstellung von neuen dehydro- digopeptiden
AT353987B (de) Verfahren zur herstellung von neuen spirooxazolidindionen
AT362786B (de) Verfahren zur herstellung von neuen 1-acyl-2-imidazolinen
AT358726B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT360037B (de) Verfahren zur herstellung von neuen substi- tuierten phenylguanidinen
AT360647B (de) Verfahren zur herstellung von neuen cephalos- porinverbindungen
AT351191B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT375931B (de) Verfahren zur herstellung von neuen aminoalkylfuranderivaten
AT364364B (de) Verfahren zur herstellung von neuen thiepinen
AT343623B (de) Verfahren zur herstellung von neuen n-alkyl -4-nitro-2- trifluormethyldiphenylaminen
AT360646B (de) Verfahren zur herstellung von neuen cephalos- porinen
ATA175879A (de) Verfahren zur herstellung von neuen antitumorglycosiden
ATA656076A (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT351515B (de) Verfahren zur herstellung von neuen polyenver- bindungen
AT364367B (de) Verfahren zur herstellung von neuen oxepinen
AT355210B (de) Verfahren zur herstellung von neuen 1-oxa- dethiacephalosporinen
AT355039B (de) Verfahren zur herstellung von neuen veraetherten hydroxy-benzimidazolonen, - benzoxazolonen, -benzoxazinonen,- china- zolinonen und -chinoxazolinonen
ATA566179A (de) Verfahren zur herstellung von neuen n-halogenalkyl-n-nitrosocarbamoylaziden

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification